KR20160081322A
|
|
Controlled release pharmaceutical composition comprising proton pump inhibitor as an active ingredient
|
EP2942052A1
|
|
Novel fast-dissolving granule formulation having improved solubility
|
WO2013019056A1
|
|
Novel granule formulation containing sildenafil or pharmaceutically acceptable salts thereof as an active ingredient
|
KR20130018474A
|
|
Novel granule formulation containing sildenafil or pharmaceutically acceptable salts thereof as an active ingredient
|
KR20130072446A
|
|
Novel granule formulation with improved solubility
|
KR20100130882A
|
|
Extended release nsaid compositions and preparing method thereof
|
KR20050002738A
|
|
Dispersible Tablet Formulation Containing β-lactam Antibiotics and Process for Preparing the Same
|
KR20050102207A
|
|
Pharmaceutical composition and food for recovering hangover comprising green tea catechins as an active ingredient
|
KR20050022250A
|
|
Pharmaceutical Composition for Recovering Hepatic Function Comprising Green Tea Catechins as an Active Ingredient
|
KR20050093894A
|
|
Pharmaceutical composition for preventing and treating hyperlipidemia comprising green tea catechins as an active ingredient
|
KR20050078712A
|
|
Antithrombotic agent comprising green tea catechins as active ingredient
|
KR20020077548A
|
|
Rapidly dissolving tablet and process for preparing same
|
KR20010105013A
|
|
Film-type pharmaceutical preparation for oral mucoadhesion and process for preparing the same
|
KR20010084811A
|
|
Pharmaceutical composition for preventing and treating coronary restenosis comprising catechine
|
KR20010084164A
|
|
Cytoprotective Agent Comprising Green Tea Catechins as an Active Ingredient
|
KR20010084165A
|
|
Inhibitor for Oxidative DNA Damage Comprising Green Tea Catechins as an Active Ingredient
|
KR20000067477A
|
|
2-Chloro-3-phenylamino-5-hydroxy-1,4-naphthalenedione Derivatives And Process for Preparing the Same
|
KR20000031828A
|
|
Film type formulation adhesive to oral mucose membrane and process for production thereof
|
KR20000009547A
|
|
Chewable soft tablet comprising separated active ingredients and process for preparing the same
|